NUPULSECV
NuPulse is a medical device company that develops technology to treat patients with heart failure. The device, which requires minimally invasive surgery, provides patients an alternative to medical therapy. NuPulse has a strategic and financial partnership with one of the heart failure companies in the world. NuPulse’s founders have extensive clinical, engineering, and life science experience, which will allow them, along with their strategic partner and Broadview Ventures, to alter the paradi... gm for the treatment of heart failure. The iVAS medical device (ambulatory counterpulsation) by NuPulseCV is being evaluated through a clinical trial as an option for patients who have advanced heart failure and who are no longer benefiting from guideline-directed medical therapies. The iVAS is a less invasive option that may help address heart failure symptoms (NYHA III and IV), which may allow a heart failure patient to return to daily activities. NuPulse was formed in 2010 and is headquartered in Raleigh, North Carolina, United States.
NUPULSECV
Industry:
Health Care Medical Medical Device
Founded:
2010-01-01
Address:
Raleigh, North Carolina, United States
Country:
United States
Website Url:
http://www.nupulsecv.com
Total Employee:
11+
Status:
Active
Contact:
(800) 216-1778
Total Funding:
27.45 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics Google Tag Manager WordPress Google Universal Analytics Font Awesome Apache
Similar Organizations
3Oe Scientific
3Oe Scientific accelerates the adoption of ozone technology to destroy bacteria and viruses.
5i Sciences
5i Sciences specializes in developing innovative medical products addressing the problem of airway collapse in a large market.
Ancora Heart
Ancora Heart is dedicated to helping people with heart failure feel better and live longer.
AtheroMed
AtheroMed is engaged in developing the peripheral atherectomy catheter system to enhance the treatment of below the knee disease.
Avacen Medical
Avacen Medical uses cutting edge technology that works with the body's natural adaptations for thermal regulation.
Avails Medical
Avails Medical has developed digital technology to provide accurate, rapid detection of infections.
BrainQ
BrainQ develops a platform for precision neurology therapies to treat the impaired brain using a BCI-based approach.
Calyxo
Calyxo, Inc. is an innovation-driven medical device company focused on improving care for patients with kidney stones.
CorVent Medical
CorVent Medical is developing smart, versatile, lifesaving ventilators for critical care.
Vero Biotech
Vero Biotech is a biopharmaceutical company that commercializes inhaled nitric oxide delivery systems for healthcare providers.
Healcerion
HEALCERION is a Korean incubator that offers a mobile-based healthcare system for providing physicians and patients with ultra-portability.
Farapulse
Farapulse commercializing an innovative collection of catheter-based tools used to treat atrial fibrillation.
JACE Medical
JACE Medical creates innovative, transformational technologies that facilitate optimal patient treatment, recovery, and future wellness.
Lungcare
Lungcare specializes in electromagnetic navigation technology for health care.
Magenta Medical
Magenta Medical is engaged in the development of novel device solutions for the treatment of acute and chronic heart failure.
NVision Imaging Technologies
Quantum MRI agents for assessing early patient response to treatment at the metabolic level
Nesos
Nesos develops wearable interfaces and software components for the treatment of neurological disorders.
Penta Medical
Wearable technology from sensing and tracking to active healing of soft tissue injuries.
PerceptiMed
PerceptiMed develops an advanced pill identification system designed to eliminate human errors in medication dispensing in pharmacies.
Perfuze
Perfuze is developing innovative medical technology to treat acute ischemic stroke.
ProSomnus Sleep Technologies
ProSomnus designs and manufactures intraoral devices designed to help dentists get patients into therapy with comfort.
Sonify Biosciences
Sonify Biosciences specializes in developing melanoma treatment based on non-chemical, non-ablative ultrasound technology.
Supira Medical
Supira Medical is developing a next-generation percutaneous ventricular assist device .
V-Wave
V Wave develops an implant for the treatment of congestive heart failure.
Vesper Medical
Vesper Medical is committed to developing safe, efficacious and easy-to-use products for patients.
VisionCare Ophthalmic Technologies
VOT develops visual prosthetic devices to improve vision in patients with end-stage age-related macular degeneration.
Current Employees Featured
Founder
Investors List
Venture Connect Online
Venture Connect Online investment in Venture Round - NuPulseCV
Broadview Ventures
Broadview Ventures investment in Series A - NuPulseCV
Official Site Inspections
http://www.nupulsecv.com
- Host name: 104.21.1.75
- IP address: 104.21.1.75
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "NuPulseCV"
Voyage - NuPulseCV
Designed to be minimally invasive and replaceable, NuPulse Voyage is currently implanted in the operating room and will eventually be implanted in a hybrid operating room suite or …See details»
About Us - NuPulseCV
NuPulseCV, Inc. is a Raleigh, NC based company working to transform the way advanced heart failure patients are treated.See details»
NuPulseCV - Crunchbase Company Profile & Funding
NuPulse is a medical device company that develops technology to treat patients with heart failure. The device, which requires minimally invasive surgery, provides patients an alternative to …See details»
NuPulse, Inc. | LinkedIn
Contact us at [email protected] or 1-800-216-1778. NuPulse, Inc. | 1,616 followers on LinkedIn. The NuPulse Freedom and Voyage percutaneous heart support med devices are for patients who have...See details»
NuPulse Company Profile 2024: Valuation, Funding & Investors
Developer of cardiovascular medical devices designed to treat patients with advanced chronic heart failure.See details»
The First in New England to Assess the NuPulseCV …
Nov 27, 2019 · The NuPulseCV Intravascular Ventricular Assist system (iVAS) is a novel, minimally invasive mechanical circulatory support device that provides long-term support for patients with advanced heart failure who are not …See details»
Clinical Outcomes and Quality of Life With an …
Apr 8, 2020 · The NuPulseCV intravascular ventricular assist system (iVAS) provides extended duration ambulatory counterpulsation via a durable pump placed through the distal subclavian artery.See details»
NuPulseCV | North Carolina Biotech Center
NuPulseCV is developing an implantable cardiovascular left ventricular assist device to treat people suffering from congestive heart failure. Company Location https://nupulsecv.comSee details»
Technology - NuPulseCV
What is iVAS? The intravascular ventricular assist system (iVAS) is a novel investigational device for the treatment of advanced heart failure. It is a minimally invasive, non-obligatory device designed to allow patients to be discharged …See details»
NuPulseCV - Contacts, Employees, Board Members, Advisors
NuPulseCV has 3 current employee profiles, including President Sonna Patel-Raman. NuPulse specializes in developing technology designed to treat patients with heart failure.See details»
NuPulseCV - Funding, Financials, Valuation & Investors - Crunchbase
NuPulse specializes in developing technology designed to treat patients with heart failure.See details»
Nupulsecv Inc Company Profile | Raleigh, NC - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Nupulsecv Inc of Raleigh, NC. Get the latest business insights from Dun & Bradstreet.See details»
The intravascular ventricular assist system: A promising therapy in ...
Nov 13, 2017 · The success of the novel NuPulseCV intravascular ventricular assist system (iVAS) in the First-In-Human (FIH) study promises to fulfill an unmet need for patients with …See details»
NuPulseCV - Overview, News & Similar companies | ZoomInfo.com
Feb 25, 2018 · NuPulseCV is a cardiovascular medical device company headquartered in Raleigh, North Carolina. It's developing a novel, implantable pump to treat people suffering …See details»
The first-in-human experience with a minimally invasive, …
Jan 1, 2018 · The NuPulseCV iVAS is a novel, minimally invasive, ambulatory heart assist system that provides counterpulsation to the failing circulation. In this FIH study of aCHF patients who …See details»
NuPulseCV evaluating new intravascular ventricular assist system
Apr 2, 2019 · Closely-held NuPulseCV is enrolling patients with advanced heart failure in a feasibility study with its intravascular ventricular assist system (iVAS), a minimally invasive …See details»
NEWS AND EVENTS - NuPulseCV
Since Gibbon developed the cardiopulmonary bypass in 1953, collaborative efforts by medical centers, bioengineers, industry, and the National Institutes of ... Heart health — How vigilance …See details»
NuPulseCV - Tech Stack, Apps, Patents & Trademarks - Crunchbase
NuPulse specializes in developing technology designed to treat patients with heart failure.See details»
NupulseCV has received a strategic investment from Nihon Kohden
Target Description: NuPulseCV Inc. is a cardiovascular medical device company headquartered in Raleigh, North Carolina, focusing on developing a novel, implantable pump to treat people …See details»
Clinical Trial - NuPulseCV
The iVAS device is an investigational device that is being evaluated in a United States clinical trial. The iVAS Feasibility Trial is not currently enrolling patients with advanced heart failure. …See details»